Latest

``` On Tuesday, Goldman Sachs notified employees that there will be a new round of layoffs this year, as the bank seeks to further cut costs across various business sectors and take advantage of new opportunities brought by artificial intelligence. Goldman Sachs stated that it will limit headcount growth before the

``` On Tuesday, ECB President Lagarde stated that although she reiterated that monetary policy and the economy are in good shape, she cannot yet declare that the rate-cutting cycle is over. When the media asked Lagarde whether monetary easing had ended, she replied, “I would never say that, because I believe

``` The International Energy Agency (IEA) stated that the current oil supply surplus has exceeded expectations, and the global oil market will experience a record supply glut next year, with oil prices remaining under pressure. In its latest monthly report, the IEA said that global oil supply next year will exceed

``` The world’s two largest aircraft manufacturers, Boeing and Airbus, are facing “unprecedented” delays in aircraft certification and delivery, severely impacting airlines’ expansion plans and decarbonization goals. Ben Smith, CEO of the Air France-KLM Group, warned at an online press conference for European airlines on Tuesday that the wait time

``` Citibank delivered strong performance in its third quarter financial report, with revenue of $22.1 billion, up 9% year-on-year. More importantly, all five major core business segments posted comprehensive growth, each achieving record third-quarter revenues, reflecting that Citibank’s recent business restructuring and investment in digital transformation are beginning to

``` As the car-to-charger ratio in the domestic market reaches 2.5:1, range anxiety among new energy vehicle users is easing, and achieving further growth has become a new challenge for many charging pile companies. "Seeking growth overseas" is gradually becoming a consensus in the industry. With the

Thanks to the momentum from the medical technology division and new drugs, Johnson & Johnson delivered a third-quarter report card that exceeded market expectations. The company plans to separate its slower-growing orthopedics business from the rest of its operations within 18 to 24 months, aiming to give its innovative drug